The Hartford Healthcare Fund Cl R3 (HGHRX) Forecast
See the Price Targets and Ratings of:
HGHRX Analyst Rating
Strong Buy
79ConsensusRatings
74Buy5Hold0Sell
Based on the Wall Street analyst consensus for 79 of HGHRX’s holdings.
HGHRX Analyst Price Target
Average Price Target
$55.58▲(20.54% Upside)
Based on Wall Street analyst 12-month price targets for 79 of The Hartford Healthcare Fund Cl R3’s holdings in the last 3 months. The average price target is $55.58 with a high forecast of $65.64 and a low forecast of $42.54. The average price target represents a 20.54% change from the last price of $46.11.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$65.64
Average$55.58
Low$42.54
Past 12 Months12 Month Forecast$36$43.5$51$58.5$66Feb2026May2026Aug2026Nov2026Nov2027
What is HGHRX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 79 of HGHRX’s holdings, The Hartford Healthcare Fund Cl R3’s 12-month average price target is $55.58.
What is HGHRX’s upside potential, based on the analysts’ average price target?
HGHRX’s average price target of $55.58 represents a 20.54% upside from its last price of $46.11.
Is HGHRX a Buy, Sell or Hold?
The Hartford Healthcare Fund Cl R3 has a consensus rating of Strong Buy, based on the analyst consensus for 79 of HGHRX’s holdings: 74 rated Buy, 5 rated Hold and 0 rated Sell.
What is The Hartford Healthcare Fund Cl R3’s price target?
The average price target for The Hartford Healthcare Fund Cl R3 is $55.58, based on Wall Street analyst 12-month price targets for 79 of HGHRX’s holdings, issued in the past 3 months. The highest price target is $65.64 and the lowest is $42.54. The average price target represents a 20.54% increase from the last price of $46.11.
How can I buy shares of HGHRX?
You can buy shares of HGHRX through a brokerage account. Compare brokers on our Best Online Brokers page.